MedTrace Logo

Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers

NCT03110796 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2019-01-17

No results posted yet for this study

Summary

Evaluation of the efficacy and safety of a device with LU3103209 compound versus the same device, free of LU3103209 compound, in the local management of DFUs.

Conditions

  • Diabetic Foot Ulcer

Interventions

DEVICE

Dressing with LU3103209 - Dose 1

Dressing with LU3103209 - Dose 1

DEVICE

Dressing with LU3103209 - Dose 2

Dressing with LU3103209 - Dose 2

DEVICE

Dressing without LU3103209

Dressing without LU3103209

Sponsors & Collaborators

  • Laboratoires URGO

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Czechia
  • France
  • Italy
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03110796 on ClinicalTrials.gov